Nicole Grunenberg - Concepedia

Author

Nicole Grunenberg

Also Known As

Carmen Paez, Derek W. Cain, Grunenberg, Nicole, N. Grunenberg, Neradilek, Moni, Nicole A Grunenberg, Nicole A. Grunenberg, Nicole Grunenberg, Robert M. Grossberg

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center National Institute of Allergy and Infectious Diseases National Institutes of Health Aurum Institute University of Cape Town

About

Nicole Grunenberg is an author at Fred Hutch Cancer Center specializing in medicine, vaccination, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	149
2	Epidemiology	3	3	61
3	Public Health	2	2	36
4	Health Sciences	1	1	31
5	Global Health	1	1	14

Nicole Grunenberg

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults Glenda Gray, Linda‐Gail Bekker, Fatima Laher, New England Journal of Medicine	2021	221
Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies Wilton B. Williams, Hua-Xin Liao, M. Anthony Moody, Science	2015	202
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial Kenneth H. Mayer, Kelly E. Seaton, Yunda Huang, PLoS Medicine	2017	129
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg, The Lancet HIV	2018	121
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention Lindsey R. Baden, Etienne Karita, Gaudensia Mutua, Annals of Internal Medicine	2016	84
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa Glenda Gray, Ying Huang, Nicole Grunenberg, Science Translational Medicine	2019	68
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder Charlotte Eltink, Jennifer Lee, Marloes Schaddelee, International Journal of Clinical Pharmacology and Therapeutics	2012	54
Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults Yunda Huang, Lily Zhang, Julie E. Ledgerwood, mAbs	2017	51
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines Fatima Laher, Zoe Moodie, Kristen W. Cohen, PLoS Medicine	2020	48
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk Zoe Moodie, One Dintwe, Sheetal Sawant, The Journal of Infectious Diseases	2022	47

Page 1